Current Value of Holding

$1.58B

Shares

32.5M

% of Portfolio

0.97%

Average Buy Price

$12.3

Avg closing price
Price range

53 PRIMECAP Management Boston Scientific Trades

PRIMECAP Management's position in Boston Scientific is currently worth $1.58B. That's 0.97% of their equity portfolio (23rd largest holding). The first Boston Scientific trade was made in Q1 2013. Since then PRIMECAP Management bought shares sixteen more times and sold shares on 36 occasions. The stake costed the investor $399M, netting the investor a gain of 296% so far.

Avg closing price
Price range
Increased shares by 4.6% (+1.43M shares) Q1 2026
Avg closing price $83.52
Price range $62.75 - $98.65
Sold 6.1% shares (-2.01M shares) Q4 2025
Avg closing price $98.08
Price range $91.72 - $104.98
Sold 4.5% shares (-1.56M shares) Q3 2025
Avg closing price $103.60
Price range $97.03 - $108.14
Sold 5.0% shares (-1.83M shares) Q2 2025
Avg closing price $101.14
Price range $89.70 - $107.41
Sold 1.2% shares (-433k shares) Q1 2025
Avg closing price $100.67
Price range $89.38 - $106.18
Sold 2.4% shares (-897k shares) Q4 2024
Avg closing price $88.16
Price range $83.62 - $91.51
Sold 0.3% shares (-133k shares) Q3 2024
Avg closing price $78.83
Price range $72.96 - $84.00
Increased shares by 0.0% (+11.4k shares) Q2 2024
Avg closing price $73.20
Price range $67.33 - $77.71
Increased shares by 0.1% (+42k shares) Q1 2024
Avg closing price $64.30
Price range $57.60 - $68.62
Increased shares by 1.5% (+550k shares) Q4 2023
Avg closing price $53.38
Price range $48.64 - $57.81
Sold 0.2% shares (-73.8k shares) Q3 2023
Avg closing price $52.45
Price range $50.19 - $54.68
Sold 2.3% shares (-899k shares) Q2 2023
Avg closing price $52.23
Price range $49.72 - $54.64
Increased shares by 1.8% (+676k shares) Q1 2023
Avg closing price $47.13
Price range $45.09 - $50.03
Increased shares by 0.0% (+1.55k shares) Q4 2022
Avg closing price $43.30
Price range $39.56 - $47.20
Sold 0.4% shares (-169k shares) Q3 2022
Avg closing price $40.12
Price range $36.71 - $43.46
Sold 0.3% shares (-101k shares) Q2 2022
Avg closing price $40.71
Price range $35.24 - $47.10
Sold 0.5% shares (-198k shares) Q1 2022
Avg closing price $43.34
Price range $40.90 - $45.10
Sold 3.8% shares (-1.49M shares) Q4 2021
Avg closing price $42.02
Price range $38.07 - $44.87
Sold 1.0% shares (-413k shares) Q3 2021
Avg closing price $44.24
Price range $41.23 - $45.88
Sold 2.4% shares (-992k shares) Q2 2021
Avg closing price $42.07
Price range $38.58 - $44.24

News about Boston Scientific Corp. and PRIMECAP Management

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!